Christopher Chappel is a clinical research site located in Kissimmee, Florida, United States 34744.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Christopher Chappel has participated in 1 clinical trials.
Therapeutic areas: Arthritis, Rheumatoid.
Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Christopher Chappel has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Christopher Chappel has 1 clinical trials on record. Their work covers Arthritis, Rheumatoid.
Christopher Chappel has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.